- Home
- BIGC vs MAZE Comparison
BIGC vs MAZE Comparison
Compare BIGC & MAZE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BIGC
- MAZE
- Stock Information
- Founded
- BIGC 2009
- MAZE 2018
- Country
- BIGC United States
- MAZE United States
- Employees
- BIGC N/A
- MAZE N/A
- Industry
- BIGC Computer Software: Prepackaged Software
- MAZE
- Sector
- BIGC Technology
- MAZE
- Exchange
- BIGC Nasdaq
- MAZE NYSE
- Market Cap
- BIGC 386.9M
- MAZE 367.0M
- IPO Year
- BIGC 2020
- MAZE 2025
- Fundamental
- Price
- BIGC $4.98
- MAZE $16.93
- Analyst Decision
- BIGC Hold
- MAZE Strong Buy
- Analyst Count
- BIGC 7
- MAZE 4
- Target Price
- BIGC $7.64
- MAZE $23.50
- AVG Volume (30 Days)
- BIGC 628.3K
- MAZE 127.7K
- Earning Date
- BIGC 07-31-2025
- MAZE 08-14-2025
- Dividend Yield
- BIGC N/A
- MAZE N/A
- EPS Growth
- BIGC N/A
- MAZE N/A
- EPS
- BIGC N/A
- MAZE 0.34
- Revenue
- BIGC $334,937,000.00
- MAZE $167,500,000.00
- Revenue This Year
- BIGC $5.06
- MAZE N/A
- Revenue Next Year
- BIGC $5.25
- MAZE N/A
- P/E Ratio
- BIGC N/A
- MAZE $52.61
- Revenue Growth
- BIGC 5.33
- MAZE N/A
- 52 Week Low
- BIGC $4.73
- MAZE $6.71
- 52 Week High
- BIGC $8.50
- MAZE $18.02
- Technical
- Relative Strength Index (RSI)
- BIGC 48.32
- MAZE N/A
- Support Level
- BIGC $4.76
- MAZE N/A
- Resistance Level
- BIGC $5.24
- MAZE N/A
- Average True Range (ATR)
- BIGC 0.16
- MAZE 0.00
- MACD
- BIGC -0.01
- MAZE 0.00
- Stochastic Oscillator
- BIGC 44.91
- MAZE 0.00
About BIGC BigCommerce Holdings Inc. Series 1
BigCommerce Holdings Inc is engaged in offering Software-as-a-service (SaaS) e-commerce platform. The company's SaaS platform engages in the creation of online stores by delivering a combination of ease-of-use, enterprise functionality, and flexibility. It powers both the customers' branded ecommerce stores and their cross-channel connections to popular online marketplaces, social networks, and offline point-of-sale systems. The group operates in a single segment covering geographical areas of Americas-U.S.; Americas-other; EMEA; and APAC, of which majority of revenue is generated from Americas-U.S.
About MAZE MAZE THERAPEUTICS INC
Maze Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of human genetics to develop novel, small-molecule precision medicines for patients living with renal, cardiovascular and related metabolic, or CVRM, diseases, including obesity. The company is advancing a pipeline using its Compass platform, which allows the company to identify and characterize genetic variants in disease and then link those variants to the biological pathways that drive disease in specific patient groups through a process it refers to as variant functionalization. It is currently advancing two programs, MZE829 and MZE782, each of which represents a novel precision medicine-based approach for chronic kidney disease, or CKD.